
- /
- Supported exchanges
- / US
- / PTPI.PINK
Petros Pharmaceuticals Inc (PTPI PINK) stock market data APIs
Petros Pharmaceuticals Inc Financial Data Overview
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Petros Pharmaceuticals Inc data using free add-ons & libraries
Get Petros Pharmaceuticals Inc Fundamental Data
Petros Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 5 112 K
- EBITDA: -7 430 266
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-28
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Petros Pharmaceuticals Inc News

EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical co...


The Urvan Group Issues Letter to AMMO Inc. Shareholders Regarding its Nomination of a Full Slate of Highly Qualified Candidates for Election to the Company’s Board of Directors
Delivers Overview of New Strategy for Leveraging AMMO’s Existing Assets and Evolving the Company into a Diversified, Growing and Profitable Ecommerce Powerhouse Highlights Long-Term Opportunity to ...

Petros Pharmaceuticals Responds to Fraudulent Press Release
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today confirmed that a press release issued on July ...

Petros Pharmaceuticals to be Acquired by Henry Crown and Company for $3.25 per share
Petros Pharmaceuticals to become a privately-owned company operating independently as part of Henry Crown and Company’s healthcare platform Petros Pharmaceuticals common shareholders will receive $...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.